Home›Compare›MangoRx vs Willow

MangoRx vs Willow: Which Is Better?

Head-to-head comparison of MangoRx and Willow based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

MangoRx scores higher overall in our independent evaluation (58/100 vs 51.9/100), leading on trust & safety, value, product range, reputation. Willow comes out ahead on experience.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
52
Willow
Below Average

Women-focused compounded GLP-1 telehealth brand operating in a limited number of states, tied to a National Advertising Division referral over its marketing claims.

Visit Willow

Score Breakdown

DimensionMangoRxWillow
Overall Score58/100 ✓51.9/100
Trust & Safety30%55/100 ✓48/100
Value25%62/100 ✓52/100
Experience20%58/10062/100 ✓
Product Range15%66/100 ✓55/100
Reputation10%45/100 ✓38/100

At a Glance

Founded2021—
HeadquartersDallas, TX—
Publicly tradedYes (MGRX)No
Treatment categories52
Treatments listed52
Starting price$50/mo$299/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxWillow
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
$299
Compounded Semaglutide

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Willow

+Women-focused positioning with unlimited doctor access included in plan price
+Reviewers highlight responsive, board-certified doctors and simple onboarding
+Some patients report substantial results (e.g., 65 lbs in three months)
−Reportedly referred by the National Advertising Division to state attorneys general (Dec 2025) over advertising claims — unverified independently this cycle, needs manual confirmation
−Service limited to a narrow footprint (reportedly ~12 states), well below most national competitors
−Pricing ($299-399/mo starting) runs higher than several direct compounded-GLP-1 competitors
Read the full Willow review →

MangoRx vs Willow — FAQ

Is MangoRx better than Willow?

▾

MangoRx scores higher overall in our independent evaluation (58/100 vs 51.9/100), leading on trust & safety, value, product range, reputation. Willow comes out ahead on experience.

Is MangoRx or Willow cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $299/mo for Willow). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Willow both offer?

▾

Both platforms treat Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and Willow covers 2.

Still deciding?

MangoRx alternativesWillow alternativesTake the Match Quiz